Reported results
- Net product revenue was $10,277 thousand for the three months ended September 30, 2026, compared to $0 for the prior year period.
- Net loss was $93,711 thousand, or $1.30 per share, for the third quarter of 2026, compared to a net loss of $80,293 thousand, or $1.26 per share, for the third quarter of 2025.
- Research and development expenses were $41,253 thousand for the three months ended September 30, 2026, compared with $56,473 thousand in the prior-year quarter.
- Selling, general and administrative expenses were $61,430 thousand for the third quarter of 2026, compared with $27,459 thousand during the prior year period.
- Cash, cash equivalents, and marketable securities totaled $384,042 thousand as of September 30, 2026.
Price and volatility reaction
The stock moved -1.2% on the print. No front-expiry chain was on file, so there is no straddle expected move. 30-day ATM implied volatility moved +1.4 vol points across the event (constant-maturity series — not the front-week crush).
| Measure | Value | Basis |
|---|---|---|
| Close before release | 30.14 | 2026-11-05 |
| Close after release | 29.785 | 2026-11-06 |
| Realised move | -1.2% | close to close |
| 30d ATM IV change | +1.4 vol pts | constant-maturity series, not the front expiry |
Source
The figures above come from the earnings release the company filed with the SEC on 2026-11-05 (8-K, Item 2.02). Read the original filing on sec.gov.
